PHINMA Energy Corp (PHEN):電力:M&Aディール及び事業提携情報

◆英語タイトル:PHINMA Energy Corp (PHEN) - Power - Deals and Alliances Profile
◆商品コード:DATA904C3539
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィリピン
◆産業分野:電力
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PHINMA Energy Corp (PHINMA), formerly Trans-Asia Oil and Energy Development Corp, is an oil and gas company that explores and develops oil and gas interest and geothermal energy. The company operates through business division such as power, wind energy, and energy resource development. Its power business division electricity supplying and distribution, marketing and power generation services. PHINMA operates power plants in Bulacan, La Union and Guimaras. The company has installed wind measuring device in two sites in Cagayan and three in Guimaras. It also explores, develops and produces oil and gas, energy, and geothermal resources. PHINMA is headquartered in Makati, the Philippines.

PHINMA Energy Corp (PHEN) – Power – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Power eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PHINMA Energy Corp, Power, Deals By Year, 2012 to YTD 2018 5
PHINMA Energy Corp, Power Deals By Type, 2012 to YTD 2018 6
PHINMA Energy Corp, Power, Deals By Region, 2012 to YTD 2018 7
PHINMA Energy Corp, Power, Deals By Sector, 2012 to YTD 2018 8
PHINMA Energy Corp, Power, Deals Summary, 2012 to YTD 2018 9
PHINMA Energy Corp, Power, Deal Details 10
Asset Purchase 10
Trans-Asia Oil and Energy Development To Acquire 10% Stake In Mabini Geothermal Power Plant From Basic Energy 10
Trans-Asia To Acquire 50% Stake In Trans-Asia Power Generation Plant From Holcim Philippines 11
Trans-Asia Plans To Invest US$315 Million In Coal-Fired Power Plant In Mindanao, Philippines 12
Trans-Asia Renewable Completes Project Financing Of US$97 Million For Guimaras Wind Farm, Philippines 13
Trans-Asia And AC Energy Announce Project Financing Of US$171 Million For Phase II Of South Luzon Project In Batangas, Philippines 14
Equity Offering 15
Trans-Asia Oil Completes Rights Offering Of Shares For US$39.4 Million 15
Asset Transactions 16
Marubeni Acquires 20% Stake in Puting Bato Thermal Power Station in Calaca, Batangas, Philippines from PHINMA Energy and AC Energy 16
PHINMA Energy Corp – Key Competitors 17
PHINMA Energy Corp – Key Employees 18
PHINMA Energy Corp – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Apr 27, 2018: Phinma Revives Plans For LNG Terminal In Philippines 20
Apr 14, 2018: Phinma: Revives Plan To Put Up LNG Terminal 21
Feb 26, 2018: Phinma Energy to start running P4-billion wind farm by 2020 22
Oct 07, 2017: PHINMA Energy Planning 3 LNG Facilities For Combined 904MW 23
Sep 14, 2017: PHINMA Energy sues PSALM over IPPA deal 24
Sep 13, 2017: Phinma to build 45-MW solar station in Batangas 25
Aug 07, 2017: First Gen Still Interested In LNG ‘Megaproject’ 26
Jun 12, 2017: Maibarara 2 geothermal power plant’s 12MW expansion work to be completed by 2017 in Philippines 27
Feb 26, 2017: Philippines Department of Energy to convert Malaya power plant into LNG facility 28
Jan 05, 2017: Philippines DOE: Result of 2nd Open and Competitive Selection Process 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
PHINMA Energy Corp, Power, Key Facts, 2017 2
PHINMA Energy Corp, Power, Deals Summary, 2012 to YTD 2018 2
PHINMA Energy Corp, Power, Deals By Year, 2012 to YTD 2018 5
PHINMA Energy Corp, Power Deals By Type, 2012 to YTD 2018 6
PHINMA Energy Corp, Power, Deals By Region, 2012 to YTD 2018 7
PHINMA Energy Corp, Deals By Sector, 2012 to YTD 2018 8
PHINMA Energy Corp, Power, Deals Summary, 2012 to YTD 2018 9
Trans-Asia Oil and Energy Development To Acquire 10% Stake In Mabini Geothermal Power Plant From Basic Energy 10
Trans-Asia To Acquire 50% Stake In Trans-Asia Power Generation Plant From Holcim Philippines 11
Trans-Asia Plans To Invest US$315 Million In Coal-Fired Power Plant In Mindanao, Philippines 12
Trans-Asia Renewable Completes Project Financing Of US$97 Million For Guimaras Wind Farm, Philippines 13
Trans-Asia And AC Energy Announce Project Financing Of US$171 Million For Phase II Of South Luzon Project In Batangas, Philippines 14
Trans-Asia Oil Completes Rights Offering Of Shares For US$39.4 Million 15
Marubeni Acquires 20% Stake in Puting Bato Thermal Power Station in Calaca, Batangas, Philippines from PHINMA Energy and AC Energy 16
PHINMA Energy Corp, Key Competitors 17
PHINMA Energy Corp, Key Employees 18
PHINMA Energy Corp, Subsidiaries 19

List of Figures
PHINMA Energy Corp, Power, Deals by Type, 2012 to YTD 2018 2
PHINMA Energy Corp, Power, Deals By Year, 2012 to YTD 2018 2
PHINMA Energy Corp, Power, Deals By Region, 2012 to YTD 2018 2
PHINMA Energy Corp, Power, Deals By Sector, 2012 to YTD 2018 2
PHINMA Energy Corp, Power, Deals By Year, 2012 to YTD 2018 5
PHINMA Energy Corp, Power, Deals by Type, 2012 to YTD 2018 6
PHINMA Energy Corp, Power, Deals By Region, 2012 to YTD 2018 7
PHINMA Energy Corp, Power, Deals by Sector, 2012 to YTD 2018 8

★海外企業調査レポート[PHINMA Energy Corp (PHEN):電力:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ZWACK Unicum Nyrt:戦略・SWOT・企業財務分析
    ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report Summary ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Powell Industries Inc (POWL):企業の財務・戦略的SWOT分析
    Powell Industries Inc (POWL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sinopec Shanghai Petrochemical Company Limited:企業の戦略・SWOT・財務分析
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Verbundnetz Gas Aktiengesellschaft-石油・ガス分野:企業M&A・提携分析
    Summary Verbundnetz Gas Aktiengesellschaft (VNG), a subsidiary of EnBW Energie Baden-Wurttemberg AG, is a natural gas company that explores, produces, stores, trades and transports natural gas. The company has natural gas licenses on the Norwegian continental shelf and the Danish Central Graben regi …
  • AmeriGas Partners LP (APU):企業の財務・戦略的SWOT分析
    Summary AmeriGas Partners LP (AmeriGas) is an oil and gas company that distributes propane liquid. The company supply propane for residential and business applications. AmeriGas propane is used in residential applications such as propane home heating, propane water heating, and propane for drying cl …
  • University of Toronto-製薬・医療分野:企業M&A・提携分析
    Summary University of Toronto (UT) is an educational and research service provider that offers undergraduate and postgraduate courses in various fields. The university offers courses in various fields such as applied science and engineering, architecture, landscape, design, arts and science, continu …
  • ContextVision AB (COV):企業の財務・戦略的SWOT分析
    Summary ContextVision AB (ContextVision) is a medical technology company that specializes in image analysis and artificial intelligence software solutions. The company develops image enhancement software solutions for magnetic resonance imaging, digital pathology, ultrasound, X-ray, fluoroscopy, mam …
  • Exosome Diagnostics Inc:企業の製品パイプライン分析
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Baker IDI Heart and Diabetes Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Baker IDI Heart and Diabetes Institute (Baker Institute) is a medical research organization that offers diagnosis, prevention, treatment of diabetics and cardiovascular disease. The organization offers clinical services such as diabetes services, weight assessment and management clinic healt …
  • Zhejiang Jingxin Pharmaceutical Co Ltd (002020):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Jingxin Pharmaceutical Co Ltd (Jingxin Pharma) is a pharmaceutical company that manufactures and markets traditional Chinese medicine. The company provides products such as finished dosage forms, Chinese herbal drugs and APIs. Its finished dosage products comprise simvastatin tablet …
  • Tenneco Inc (TEN):企業の財務・戦略的SWOT分析
    Tenneco Inc (TEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • OmniComm Systems Inc (OMCM)-医療機器分野:企業M&A・提携分析
    Summary OmniComm Systems Inc (OmniComm) is a web-based electronic data capture and eClinical software and services providing company. It provides web-based applications to pharmaceutical, biotech and medical device companies. The company’s solutions allow clinical trial sponsors and investigative si …
  • Syngene International Ltd (SYNGENE):企業の財務・戦略的SWOT分析
    Summary Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and manufacturing organisation. The organisation offers research, development and manufacturing programs. It also provides discovery chemistry, discovery biology, large molecule development, safety assess …
  • Allergan Plc (AGN):医療機器:M&Aディール及び事業提携情報
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes biogeneric drugs, vaccines and biotech products. The company develops products in the areas of oncology, auto-immunity, drug delivery and bio generics. Its products include TBL-0404, TBL-0905, TBL -0 …
  • Nissan Chemical Industries Ltd (4021):企業の財務・戦略的SWOT分析
    Nissan Chemical Industries Ltd (4021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Noble Group Ltd:企業のM&A・事業提携・投資動向
    Noble Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Noble Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Paymark:企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Coresa Sa
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Orexigen Therapeutics Inc (OREX)-製薬・医療分野:企業M&A・提携分析
    Summary Orexigen Therapeutics Inc (Orexigen) is a biopharmaceutical company which develops and commercializes indications for the treatment of obesity. Its lead product, Contrave (naltrexone HCl / bupropion HCl prolonged release) is FDA approved as an adjunct to a reduced-calorie diet and increased …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆